TrialPath
★ Long COVID

Long COVID clinical trials — recruiting now

There are 20+ long covid studies currently recruiting participants across the US. Every eligibility criterion translated into plain English.

Transcranial Pulse Stimulation (TPS) in Post-COVID-19

NCT06178952 · Post-COVID-19 Syndrome, Fatigue
Recruiting

The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.

PhaseNA
TypeInterventional
Age20 Years – 80 Years
WhereVienna, State of Vienna, Austria
SponsorMedical University of Vienna
▾Tap for details
Apply

Heat thErapy And mobiLity in COVID-19 Survivors

NCT06928116 · Long COVID
Recruiting

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".

PhaseNA
TypeInterventional
Age50 Years – 90 Years
WhereOmaha, Nebraska, United States
SponsorUniversity of Nebraska
▾Tap for details
Apply

RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis

NCT06933173 · Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Recruiting

We are studying the effect of a mind-body treatment for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with or without Long COVID (LC). Our team recognizes that ME/CFS and Long COVID are serious, debilitating, biomedical conditions. ME/CFS can affect many different parts of the body, such as the nervous system, immune system, and metabolism. It is hypothesized that central sensitization (i.e., when nerves get too excited) may influence these complex conditions and may make symptoms worse. This study explores a mind-body program called the Dynamic Neural Retraining System™, or DNRS™. Mind-body interventions (MBIs) focus on how the brain, mind, body, and behaviour interact to improve health and well-being. These techniques help people become more aware of themselves, take better care of their health, and boost mood, quality of life, and coping skills. MBIs use the brain's ability to change (neuroplasticity) by reinforcing certain thoughts, feelings, or behaviours that support changes in biology and function. MBIs may influence physical health by affecting how the brain and body communicate through chemicals such as hormones and neurotransmitters. Objective fMRI evidence shows that practising MBIs can change brain structure and function. This makes MBIs a potential good fit for people with chronic illnesses like ME/CFS and LC, which involve complex interactions between the brain, immune system, and hormones. There is no rigorous peer-reviewed evidence that DNRS is effective. Our study will address this question using subjective and objective measurements in a multiple-methods wait-list randomized controlled trial. The objectives of this study are to: 1) examine the effectiveness of the DNRS program for individuals diagnosed with ME/CFS with and without Long COVID, compared to a treatment-as-usual wait-list control group on a range of patient-reported outcomes including health-related quality of life, fatigue, pain, anxiety and depression and objective measures including daily steps, heart rate variability, and sleep; 2) quantify metabolic changes through untargeted serum metabolomics profiling, 3) determine if metabolomics screening can predict treatment responsiveness to DNRS; and 4) identify the microbial signatures of large bowel microbiota in Long COVID patients pre and post MBI. A descriptive qualitative study will also be conducted in a sample of participants to learn more about their experiences during the trial.

PhaseNA
TypeInterventional
Age18 Years
WhereCalgary, Alberta, Canada + 1 more
SponsorUniversity of Alberta
▾Tap for details
Apply

Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)

NCT07295483 · Persistent COVID Condition
Recruiting

Long COVID (persistent COVID) represents a major global health challenge due to its high prevalence (approximately 7%), significant impact on quality of life, and socioeconomic burden. Despite extensive research, diagnostic tools to objectively identify or predict long COVID evolution are still lacking. The BioICOPER Follow-up Study aims to analyze the influence of biomarker evolution on clinical symptomatology (particularly chronic fatigue) and vascular health after four years of follow-up among 400 participants previously included in the original BioICOPER cohort. Advanced proteomic analysis, vascular function assessment, and machine-learning-based predictive modeling will be used to identify biomarkers associated with disease progression, stratified by sex. This project will contribute to personalized clinical management of long COVID and improved diagnostic and therapeutic strategies in primary care.

Phase—
TypeObservational
Age18 Years
WhereSalamanca, Salamanca, Spain
SponsorInstituto de Investigación Biomédica de Salamanca
▾Tap for details
Apply

Taurine Supplementation in Long COVID

NCT06721949 · Long COVID
Recruiting

The COVID-19 pandemic has swept across the globe, affecting millions of individuals with varying degrees of severity. While many individuals recover from the acute phase of the infection, a significant proportion continue to experience persistent and debilitating symptoms long after the initial SARS-CoV-2 infection. This condition, known as Long COVID (LC) or sometimes referred to as Post-COVID Condition (PCC) or post-acute sequelae of COVID-19, has emerged as a complex multisystemic condition and challenging health issue, affecting approximately 10% of COVID-19 patients. Various symptoms characterize LC, including fatigue, sleep disturbances, cognitive impairment, and mood disturbances. Some of the symptoms are shared with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a condition marked by debilitating fatigue and a host of other symptoms without precise biomarkers or objective tests for diagnosis. Effective LC treatments remain elusive and LC patients continue to grapple with persistent symptoms that significantly impact their quality of life. Given the lack of effective treatments, it is imperative to explore novel therapeutic approaches that may alleviate the suffering of this patient population.

PhasePhase 2 / Phase 3
TypeInterventional
Age18 Years
WhereEdmonton, Alberta, Canada + 4 more
SponsorUniversity of Alberta
▾Tap for details
Apply

Presynaptic Imaging in Major Depressive Episodes After COVID-19

NCT06086366 · Long COVID, Major Depressive Disorder, Major Depressive Episode
Recruiting

The goal of this observational study focuses on understanding and addressing a subset of persistent neuropsychiatric symptoms occurring within 3 months after mild to moderate COVID-19 infection (COVID-DNP). COVID-DNP encompasses major depressive episodes (MDE) with or without additional neuropsychiatric symptoms.

Phase—
TypeObservational
Age18 Years – 75 Years
WhereToronto, Ontario, Canada
SponsorCentre for Addiction and Mental Health
▾Tap for details
Apply

Mitochondrial Function in Peripheral Blood Mononuclear Cells, Muscle, and Skin of Long COVID Patients

NCT07134673 · Long COVID, Post-COVID-19 Condition
Recruiting

Mitochondria are structures inside cells that are responsible for producing energy from nutrients through a series of steps, using oxygen. To have an idea of how well the mitochondria can produce energy, we can measure how much oxygen they use. The goal of this study is to: 1. To compare the oxygen use between people with long COVID and people who completely recovered after COVID-19, using three techniques that measure the oxygen use in blood cells, on the skin and in the muscle 2. To test how similar these three techniques are in measuring the oxygen used in the three different tissues Participants will: * Complete surveys, * Wear an activity tracker (7 days), * Undergo several non-invasive tests, and * Donate a blood sample The study will take place in UZ Brussel hospital and will take 2 study visits, approximately 7 days apart.

Phase—
TypeObservational
Age18 Years
WhereJette, Brussels Capital, Belgium
SponsorUniversitair Ziekenhuis Brussel
▾Tap for details
Apply

DAOIB for the Treatment of Brain Fog

NCT05764538 · Long COVID
Recruiting

This is a 24-week open trial. We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks. We will assess the patients every 8 weeks during the treatment period (weeks 0, 8, 16, and 24). We hypothesize that DAOIB treatment will be beneficial in improving the cognitive function, mood symptoms, global functioning and quality of life in long-COVID patients with cognitive impairments.

PhasePhase 2
TypeInterventional
Age18 Years – 100 Years
WhereKaohsiung City, Taiwan
SponsorChang Gung Memorial Hospital
▾Tap for details

NC Testing in LC & POTS

NCT05914649 · Postural Orthostatic Tachycardia Syndrome, Post Acute Sequelae of SARS CoV 2 Infection
Recruiting

Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or "Long COVID") experience cognitive dysfunction. The investigators will test the hypothesis that 999 mL of IV saline will improve cognitive function in patients with POTS and Long COVID compared to placebo (50 mL of saline).

PhaseNA
TypeInterventional
Age18 Years – 60 Years
WhereCalgary, Alberta, Canada
SponsorUniversity of Calgary
▾Tap for details
Apply

Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial

NCT06156176 · Long-COVID, Long COVID-19, Post-COVID-19 Syndrome
Recruiting

Long COVID is a complex condition that affects approximately 1.4 million Canadians following SARS-CoV-2 infection. Fatigue is the most common symptom of Long COVID. This feasibility trial will evaluate a new rehabilitation program called COVIDEx for treating fatigue after COVID-19, and compare its effectiveness to the standard treatment currently used. The experimental treatment group will receive an 8-week multi-modal rehabilitation program with two 50-minute sessions per week. 60 participants will be recruited, randomly assigned to the COVIDEx program or standard of care (SoC) and followed for 24 weeks.

PhaseNA
TypeInterventional
Age18 Years
WhereLondon, Ontario, Canada
SponsorLawson Research Institute of St. Joseph's
▾Tap for details
Apply

Cognitive-Sensorimotor Function in Long-COVID

NCT06850350 · Post-acute Sequelae of SARS-CoV-2 Infection
Recruiting

Growing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculoskeletal impairment that can affect gait and balance. Identifying the factors contributing to these impairments and how they influence functional mobility is the first step towards creating effective evaluation and treatment protocols. In this study the investigators will examine cognition, vision, proprioception, muscle strength, gait and balance in persons with and without PASC to understand how PASC may impact functional mobility through a cognitive-sensorimotor lens. Gait and balance will be studied in environments that stress cognitive and sensory abilities. Study outcomes will be critical for the development of evidence-based Veteran Health Administration diagnostic and standard-of-care protocols to address gait and balance dysfunction in Veterans with PASC for restoring their functional mobility and independence.

Phase—
TypeObservational
Age18 Years
WhereChicago, Illinois, United States
SponsorVA Office of Research and Development
▾Tap for details
Apply

A Study to Examine Anktiva for the Treatment of COVID-19.

Recruiting

This study will examine the safety and effectiveness of Anktiva in treating patients with Long COVID-19 which is defined as persistent symptoms of a COVID-19 infection that remain after the infection is over.

PhasePhase 2
TypeInterventional
Age18 Years – 70 Years
WhereEl Segundo, California, United States
SponsorImmunityBio, Inc.
▾Tap for details
Apply

Mind Body Intervention for Long COVID-19

NCT06045338 · Long COVID, Post-Acute Sequelae of COVID-19, COVID Long-Haul
Recruiting

The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control

PhaseNA
TypeInterventional
Age18 Years – 65 Years
WhereBoston, Massachusetts, United States
SponsorBeth Israel Deaconess Medical Center
▾Tap for details
Apply

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

NCT05855369 · Smell Dysfunction, Olfactory Disorder, Long COVID
Recruiting

Persistent smell loss that can include diminished or distorted smell function is a common symptom of long COVID syndrome. There are limited treatment options for long COVID-related smell loss. This study aims to determine the efficacy of two at-home treatments, smell training and non-invasive trigeminal nerve stimulation. This study requires participants to conduct daily at-home treatment sessions, attend three in-person study visits at the MUSC Department of Psychiatry and Behavioral Sciences, and complete electronic questionnaires over the 12-week trial, and again at the six-month timepoint. Participants in this trial may benefit directly with an improvement in sense of smell. However, participation may also help society more generally, as this study will provide new information about long COVID-related smell loss and its treatment.

PhasePhase 2 / Phase 3
TypeInterventional
Age18 Years – 65 Years
WhereCharleston, South Carolina, United States
SponsorMedical University of South Carolina
▾Tap for details
Apply

Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

Recruiting

The PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely, the "Score of PACS progression reversal"

PhasePhase 2 / Phase 3
TypeInterventional
Age18 Years
WhereJena, Germany + 23 more
SponsorHellenic Institute for the Study of Sepsis
▾Tap for details
Apply

A Study to Assess Anktiva in Patients With Long Covid-19.

NCT07108036 · Long COVID
Recruiting

This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and have follow-up exams and tests.

PhasePhase 2
TypeInterventional
Age18 Years – 70 Years
WhereSan Francisco, California, United States
SponsorImmunityBio, Inc.
▾Tap for details
Apply

A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

NCT06006884 · COVID-19
Recruiting

The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection

Phase—
TypeObservational
Age18 Years
WhereRochester, Minnesota, United States
SponsorMayo Clinic
▾Tap for details

Effects of Hydrotherapy During Post-COVID-19 Rehabilitation

NCT07013903 · Post-COVID / Long-COVID, POST-Covid 19, Post COVID Syndrome
Recruiting

This randomized controlled study evaluates the effects of cold water hydrotherapy as an adjunct to standard rehabilitation in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to standard rehabilitation alone.

PhaseNA
TypeInterventional
Age18 Years
WhereSchönau am Königssee, Bavaria, Germany
SponsorSchön Klinik Berchtesgadener Land
▾Tap for details
Apply

Sauna for Long Covid

NCT05931497 · Long COVID
Recruiting

Research suggests that Whole Body Hyperthermia in a sauna-like environment can reduce symptoms related to post-acute sequelae of SARS-CoV-2 (PASC), or Long Covid. The investigators aim to study the feasibility and treatment effect of this procedure for patients experiencing Long Covid symptoms.

PhaseNA
TypeInterventional
Age18 Years – 65 Years
WhereBoston, Massachusetts, United States
SponsorMassachusetts General Hospital
▾Tap for details
Apply

Persistent COVID-19 Registry in Navarre.

Recruiting

The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre. Sociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID. All patient data will be collected in a single visit.

Phase—
TypeObservational
AgeAny
WherePamplona, Navarre, Spain
SponsorFundacion Miguel Servet
▾Tap for details
Apply